Clinical Trial Update: OneShot Renal Denervation Registry [Phase 2, Phase 3]

View source ↗

Summary

This document reports the termination of the OneShot Renal Denervation Registry trial (Phase 2/3). It was sponsored by Medtronic Endovascular and investigated h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Heart Failure
• Hypertension
• Sleep Apnea

Drugs mentioned

• OneShot Renal Denervation

Snippet

Sponsor: Medtronic Endovascular | Conditions: Hypertension, Heart Failure | Phase 2, Phase 3 | Status: TERMINATED